Bio: Michael L. Moeller, PhD, has worked in the CGT space for 25 years, including roles as the Chief Scientific Officer of a Biotech startup, as the Scientific Director of the CGT unit of a CRO, and multiple roles in business development at life science companies. He has advanced one of his cellular therapies into 2 Phase I Clinical Trials and is currently focused on becoming a supportive presence for the larger CGT field.
MARCH 22, 2024 3:30 PM ET
Supporting Full Workflows for Cell & Gene Therapies
Presented at:
The Thomas Experts Series & The Thomas Center Labs
Speaker
Abstract
Cellular and gene-based therapeutic approaches are the future of medicine for many conditions. As the CGT field expands and deepens, the need for consistent and reliable partners becomes critical. We will review how Thomas Scientific can assist you in your efforts.
You May Also Like
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
DEC 05, 2023 | 8:00 AM
CGX10 Cell Isolation System: Introduction, Utility, and Assessment in a GMP-grade Environment for Multiparametric Cell Sorting A future of long-term, minimally toxic immunotherapy personaliz...
DEC 12, 2023 15:00 CET
C.E. CREDITS
The implementation of the new CE-In Vitro Diagnostics Regulation (IVDR) involves challenges faced by labs that are working within the diagnostic environment. The aim of this event is to get...
Loading Comments...
Finish Registering
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024 -
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
MAY 23, 2024For the Love of Digital PCR 2024
- See More
-
APR 27, 2024
- See More
